← Open Payments lookup

CHRISTINE CALABRESE: Open Payments

NPI 1487630232 · NEW BRITAIN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,675 in 83 payments from 16 companies in 2025. Trend: 2023 $718 · 2024 $1,021 · 2025 $1,675

Food & beverage: $1,675
CompanyPaymentsAmount
ABBVIE INC.28$416
Ardelyx, Inc.21$339
Takeda Pharmaceuticals U.S.A., Inc.6$166
Aimmune Therapeutics, Inc.1$125
QOL Medical, LLC4$124
Madrigal Pharmaceuticals3$92
Lilly USA, LLC3$81
Janssen Biotech, Inc.3$63
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$55
VIVUS LLC2$42

Products named: IBSRELA, LINZESS, RINVOQ, ZENPEP, Sucraid, ENTYVIO, REZDIFFRA, TREMFYA.

Industry payments across CT — which companies pay providers there.